Flavin Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$670K Hold
2,563
– – 0.36% 52
2026
Q2
$645K Buy
2,563
+595
+30% +$128K 0.37% 54
2026
Q1
$428K Buy
1,968
+108
+6% +$24K 0.29% 60
2025
Q4
$425K Sell
1,860
-100
-5% -$22.8K 0.29% 59
2025
Q3
$454K Hold
1,960
– – 0.32% 57
2025
Q2
$364K Hold
1,960
– – 0.35% 59
2025
Q1
$411K Hold
1,960
– – 0.38% 58
2024
Q4
$348K Buy
+1,960
New +$360K 0.33% 59

Other funds holding ABBV

Flavin Financial Services's ABBV Position: Q3 2026 in Review

Flavin Financial Services held its AbbVie (ABBV) position steady in Q3 2026 at 2,563 shares worth $670K. The position accounts for 0.36% of the portfolio, ranked #52.

Flavin Financial Services first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,163 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Flavin Financial Services held 2,563 shares of AbbVie worth $670K as of Q3 2026.
  • Flavin Financial Services left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.36% of Flavin Financial Services's portfolio in Q3 2026, its #52 holding.
  • Flavin Financial Services first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,163 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Flavin Financial Services's 13F filing for Q3 2026, filed 21 Oct 2026.